DE68914922T2 - Verwendung von Inositoltrisphosphat zur Herstellung eines Arzneimittels gegen Knochenerkrakungen. - Google Patents

Verwendung von Inositoltrisphosphat zur Herstellung eines Arzneimittels gegen Knochenerkrakungen.

Info

Publication number
DE68914922T2
DE68914922T2 DE68914922T DE68914922T DE68914922T2 DE 68914922 T2 DE68914922 T2 DE 68914922T2 DE 68914922 T DE68914922 T DE 68914922T DE 68914922 T DE68914922 T DE 68914922T DE 68914922 T2 DE68914922 T2 DE 68914922T2
Authority
DE
Germany
Prior art keywords
manufacture
bone disorders
against bone
inositol trisphosphate
medicine against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68914922T
Other languages
English (en)
Other versions
DE68914922D1 (de
Inventor
Matti Siren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perstorp AB
Original Assignee
Perstorp AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp AB filed Critical Perstorp AB
Publication of DE68914922D1 publication Critical patent/DE68914922D1/de
Application granted granted Critical
Publication of DE68914922T2 publication Critical patent/DE68914922T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68914922T 1988-09-15 1989-09-14 Verwendung von Inositoltrisphosphat zur Herstellung eines Arzneimittels gegen Knochenerkrakungen. Expired - Fee Related DE68914922T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803248A SE464059C (sv) 1988-09-15 1988-09-15 Användning av inositoltrifosfat för framställning av läkemedel

Publications (2)

Publication Number Publication Date
DE68914922D1 DE68914922D1 (de) 1994-06-01
DE68914922T2 true DE68914922T2 (de) 1994-09-01

Family

ID=20373330

Family Applications (5)

Application Number Title Priority Date Filing Date
DE8989117028T Expired - Fee Related DE68904507T2 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat bei der behandlung der beschaedigung von gewebe.
DE89117032T Expired - Fee Related DE68906106T2 (de) 1988-09-15 1989-09-14 Verwendung von Inositoltriphosphat zur Herstellung eines Arzneimittels gegen abnorme Konzentrationen von Lipoproteinen.
DE68922165T Expired - Fee Related DE68922165T2 (de) 1988-09-15 1989-09-14 Verwendung von Inositoltriphosphat zur Herstellung eines Arzneimittels gegen Diabetes.
DE8989117031T Expired - Fee Related DE68902526T2 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat zur herstellung eines arzneimittels gegen stoerungen bei transplantationen.
DE68914922T Expired - Fee Related DE68914922T2 (de) 1988-09-15 1989-09-14 Verwendung von Inositoltrisphosphat zur Herstellung eines Arzneimittels gegen Knochenerkrakungen.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
DE8989117028T Expired - Fee Related DE68904507T2 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat bei der behandlung der beschaedigung von gewebe.
DE89117032T Expired - Fee Related DE68906106T2 (de) 1988-09-15 1989-09-14 Verwendung von Inositoltriphosphat zur Herstellung eines Arzneimittels gegen abnorme Konzentrationen von Lipoproteinen.
DE68922165T Expired - Fee Related DE68922165T2 (de) 1988-09-15 1989-09-14 Verwendung von Inositoltriphosphat zur Herstellung eines Arzneimittels gegen Diabetes.
DE8989117031T Expired - Fee Related DE68902526T2 (de) 1988-09-15 1989-09-14 Verwendung von inositoltriphosphat zur herstellung eines arzneimittels gegen stoerungen bei transplantationen.

Country Status (8)

Country Link
EP (5) EP0359260B1 (de)
JP (5) JP3058334B2 (de)
AT (5) ATE79542T1 (de)
DE (5) DE68904507T2 (de)
ES (5) ES2045319T3 (de)
GB (5) GB2223168B (de)
GR (4) GR3005448T3 (de)
SE (2) SE464059C (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330979A (en) * 1984-10-23 1994-07-19 Perstorp Ab Method of treating renal disorders with inositoltriphosphate
US5427956A (en) * 1989-03-08 1995-06-27 The University Of Virginia Patent Foundation Quantitative analysis for diabetic condition predictor
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
ES2146197T3 (es) * 1989-03-08 2000-08-01 Univ Virginia Suplemento dietetico para diabeticos resistentes a la insulina.
SE9002278L (sv) * 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
SE467340B (sv) * 1990-07-04 1992-07-06 Perstorp Ab Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist
JP2750239B2 (ja) * 1991-08-14 1998-05-13 三共株式会社 アデノホスチンａまたはｂならびにその製法
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
SE9600194D0 (sv) * 1996-01-19 1996-01-19 Perstorp Ab A new chemical compound
SE9601396D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 2
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
SE9602463D0 (sv) * 1996-06-24 1996-06-24 Perstorp Ab The use of growth factor modulating compounds
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
US5906979A (en) * 1998-01-27 1999-05-25 Insmed Pharmaceuticals, Inc. Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
US6486127B1 (en) 2001-05-23 2002-11-26 Insmed, Incorporated Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof
KR100653557B1 (ko) * 2001-10-06 2006-12-05 아미코젠주식회사 카이로 이노시톨 또는 피니톨의 백내장 예방치료제로서의용도와 그 조성물
CN111246852A (zh) * 2017-10-26 2020-06-05 大塚制药株式会社 含有磷酸肌醇的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel

Also Published As

Publication number Publication date
SE8803248L (sv) 1990-03-16
GB2223168B (en) 1992-08-12
JP3058334B2 (ja) 2000-07-04
DE68922165D1 (de) 1995-05-18
ATE84719T1 (de) 1993-02-15
GB8920805D0 (en) 1989-11-01
GB8920807D0 (en) 1989-11-01
EP0359258A3 (en) 1990-10-03
GR3015764T3 (en) 1995-07-31
EP0359256A2 (de) 1990-03-21
DE68904507T2 (de) 1993-06-09
ES2054965T3 (es) 1994-08-16
DE68922165T2 (de) 1995-09-14
GB2223404B (en) 1992-04-08
GB2223403B (en) 1992-02-26
EP0359257A2 (de) 1990-03-21
GB2223169A (en) 1990-04-04
EP0359256A3 (en) 1990-10-10
EP0359256B1 (de) 1993-01-20
GR3007686T3 (de) 1993-08-31
GB2223404A (en) 1990-04-11
DE68904507D1 (de) 1993-03-04
ATE104855T1 (de) 1994-05-15
SE464059C (sv) 1996-12-04
JPH02191218A (ja) 1990-07-27
GB8920811D0 (en) 1989-11-01
EP0359259A3 (en) 1990-10-03
ES2045319T3 (es) 1994-01-16
EP0359260A3 (en) 1990-10-03
JPH02191220A (ja) 1990-07-27
JP2859318B2 (ja) 1999-02-17
SE464059B (sv) 1991-03-04
GB8920804D0 (en) 1989-11-01
EP0359258A2 (de) 1990-03-21
EP0359257A3 (en) 1990-10-03
DE68914922D1 (de) 1994-06-01
ATE88347T1 (de) 1993-05-15
EP0359259A2 (de) 1990-03-21
GR3006825T3 (de) 1993-06-30
ATE120958T1 (de) 1995-04-15
JPH02191219A (ja) 1990-07-27
EP0359257B1 (de) 1995-04-12
ES2055772T3 (es) 1994-09-01
DE68906106D1 (de) 1993-05-27
JPH02191217A (ja) 1990-07-27
GB2223167B (en) 1992-02-26
EP0359258B1 (de) 1994-04-27
EP0359259B1 (de) 1992-08-19
DE68902526D1 (de) 1992-09-24
JP2547257B2 (ja) 1996-10-23
DE68902526T2 (de) 1993-03-11
ES2043998T3 (es) 1994-01-01
SE8803248D0 (sv) 1988-09-15
GB2223403A (en) 1990-04-11
SE9003395L (sv) 1992-04-25
JP2859319B2 (ja) 1999-02-17
EP0359260A2 (de) 1990-03-21
SE9003395D0 (sv) 1990-10-24
ES2073419T3 (es) 1995-08-16
DE68906106T2 (de) 1993-10-21
GB2223167A (en) 1990-04-04
GR3005448T3 (de) 1993-05-24
JPH02191221A (ja) 1990-07-27
ATE79542T1 (de) 1992-09-15
GB2223168A (en) 1990-04-04
EP0359260B1 (de) 1993-04-21
GB2223169B (en) 1992-04-08
GB8920806D0 (en) 1989-11-01

Similar Documents

Publication Publication Date Title
DE68914922D1 (de) Verwendung von Inositoltrisphosphat zur Herstellung eines Arzneimittels gegen Knochenerkrakungen.
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
ATE143260T1 (de) Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen
ATE135220T1 (de) Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose
DE69432124D1 (de) Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes
ATE98127T1 (de) Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee